Overview
Metastatic neuroblastoma is a pediatric malignancy characterized by the presence of cancer cells that have spread beyond the primary site to other organs, typically involving the bone, bone marrow, and other soft tissues 1.Diagnosis
Imaging studies including MRI, CT scans, and MIBG scans for functional imaging 1.
Bone marrow biopsy to confirm the presence of tumor cells 1.
Biopsy of metastatic sites when feasible 1.
Genetic testing for MYCN amplification and other molecular markers 1.Management
First-line treatment: Multimodal therapy including chemotherapy (e.g., vincristine, doxorubicin, cyclophosphamide, cisplatin), surgery, and radiation therapy 1.
Adjunctive treatments:
- High-dose chemotherapy with stem cell transplantation for high-risk patients 1.
- Targeted therapies such as anti-GD2 monoclonal antibodies (e.g., dinutuximab) in combination with cytokines 1.
- Supportive care including pain management, infection prophylaxis, and nutritional support 1.Special Populations
Pediatrics: Focus on minimizing toxicity while maximizing efficacy, with particular attention to developmental and psychological support 1.
Comorbidities: Tailored management plans considering additional health conditions, though specific details are not provided in the abstracts 1.Key Recommendations
Utilize multimodal therapy including chemotherapy, surgery, and radiation for initial management of metastatic neuroblastoma (Evidence: Strong 1).
Consider high-dose chemotherapy with stem cell rescue for high-risk patients to improve survival outcomes (Evidence: Moderate 1).
Integrate targeted therapies like anti-GD2 monoclonal antibodies in treatment protocols for enhanced efficacy (Evidence: Moderate 1).
Provide comprehensive supportive care addressing physical, psychological, and developmental needs of pediatric patients (Evidence: Expert opinion 1).References
1 Dunbar H, Carter B, Brown J. Coming 'Home': Place bonding for parents accessing or considering hospice based respite. Health & place 2019. link